⚠️ Serious warning: Nothing on this website is approved by any physician. Doz is only a tool to help physicians and to search drugs easily. Taking medicines without medical supervision can be fatal.

Dulaglutide

دولاگلوتاید

⚠ Unverified

🍽️ Alimentary Tract And MetabolismWeekly GLP-1 agonist

🤰 Pregnancy:Use with caution 🤱 Breastfeeding:Use with caution 👶 Children:Use with caution 👴 Older adults:No specific problem stated 🇮🇷 Not found in Iran list ⛔ 1 contraindications 🇺🇸 FDA approved (BLA) BLA125469 ATC A10BJ05

Market / country: 🇺🇸 USA

Trulicity (US)

🧮 Dose calculator

Disease / regimen

Type 2 diabetes mellitus · Regimen source: FDA Trulicity · 2.1

⛔ Once WEEKLY SC (not daily). Start 0.75 mg; after 4 weeks 1.5 mg; if needed increase by 1.5 mg after at least 4 weeks, to a max of 4.5 mg. FDA Trulicity · 2.1

🛡️ Safety & information

Contraindications

⛔ Personal or family history of medullary thyroid carcinoma or MEN 2; serious hypersensitivity. FDA Trulicity · 4

Warnings

• Boxed warning: thyroid C-cell tumours in rodents. FDA Trulicity · Boxed Warning

Formulations

Single-dose pen 0.75 / 1.5 / 3 / 4.5 mg in 0.5 mL — injection 🇺🇸 USA FDA Trulicity · 3

👥 Special populations

🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Trulicity · 8.1
“Risk Summary Limited data with TRULICITY in pregnant women are not sufficient to determine a drug-associated risk for major birth defects and miscarriage.”
🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Trulicity · 8.2
“Risk Summary There are no data on the presence of dulaglutide in human milk, the effects on the breastfed infant, or the effects on milk production.”
👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Trulicity · 8.4
“The safety and effectiveness of TRULICITY as an adjunct to diet and exercise to improve glycemic control in pediatric patients 10 years of age and older with type 2 diabetes mellitus have been established.”
👴 Older adultsNo specific problem stated
Label: no specific difference or dose adjustment stated for older adults. FDA Trulicity · 8.5
“No overall differences in safety or effectiveness for TRULICITY have been observed between patients 65 years of age and older and younger adult patients.”
⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.

🔗 Reference links

FDA (approval record)BLA125469
DailyMed (FDA label)FDA Trulicity
MedlinePlus (NIH)Dulaglutide Injection
WHO ATC/DDDA10BJ05
Darooyab (Iran)❌ None

🇮🇷 Not found in Iran list Darooyab · search

Darooyab lists no registered dosage form or brand for this drug. This does not prove it is unavailable.

📚 Reference status for this drug

Shows which sources have references recorded for this drug and which do not.

FDA label (DailyMed)✅ Present
FDA Trulicity · 3 FDA Trulicity · 2.1 FDA Trulicity · 2.2 FDA Trulicity · 4 FDA Trulicity · Boxed Warning FDA Trulicity · 8.1 FDA Trulicity · 8.2 FDA Trulicity · 8.4 FDA Trulicity · 8.5 FDA Trulicity · SPL approval / marketing category
UK SmPC (eMC / MHRA)❌ Not present
Published guideline❌ Not present
Licensed reference (medical school)❌ Not present
Iranian leaflet (IFDA)❌ Not present
Pharmacy website (secondary, unreliable)✅ Present
Darooyab · search
Clinical review⚠ Unverified